Table 1.
|
All patients |
Physical component summary-36 score quartiles |
Mental component summary-36 score quartiles |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Q 1 Range: 9.6-30.0 | Q 2 Range: 30.1-35.6 | Q 3 Range: 35.7-44.4 | Q 4 Range: 44.5–58.2 | P -value | Q 1 Range: 16.9-39.2 | Q 2 Range: 39.3-49.0 | Q 3 Range: 49.1-55.6 | Q 4 Range: 55.7-70.7 | P - value | ||
N |
252 |
63 |
63 |
63 |
63 |
|
63 |
63 |
63 |
63 |
|
Age, yrs, (252) |
60.2±15.5 |
60.8±12.4 |
64.8±14.9 |
58.1±17.3 |
57.2±16.0 |
0.027p |
56.5±15.7 |
63.7±15.3 |
60.0±17.0 |
60.6±13.0 |
0.071p |
Male gender,%, (n=252) |
65.9 (166) |
58.7 (37) |
68.3 (43) |
69.8 (44) |
66.7 (42) |
0.5632 |
61.9 (39) |
68.3 (43) |
77.8 (49) |
55.6 (35) |
0.0562 |
Current smoker, %, (n=252) |
25.8 (65) |
33.3 (21) |
23.8 (15) |
22.2 (14) |
23.8 (15) |
0.466 2 |
39.7 (25) |
22.2 (14) |
19.0 (12) |
22.2 (14) |
0.0342 |
Work status, %, (n) | |||||||||||
Able to work, (n=235) |
12.3 (29) |
8.5 (5) |
5.2 (3) |
12.1 (7) |
23.3 ( 14) |
0.016 2 |
6.7 (4) |
15.3 (9) |
12.7 (7) |
14.8 (9) |
0.4602 |
Disable to work, (n=235) |
51.5 (121) |
64.4 (38) |
43.1 (25) |
50.0 (29) |
48.3 (29) |
0.118 2 |
65.0 (39) |
35.6 (21) |
47.3 (26) |
57.4 (35) |
0.0092 |
Retired, (n=235) |
36.2 (85) |
27.1 (16) |
51.7 (30) |
37.9 (22) |
28.3 (17) |
0.02 2 |
28.3 (17) |
49.2 (29) |
40.0 (22) |
27.9 (17) |
0.0452 |
Cause of renal failure, %, (n) | |||||||||||
Glomerulonephritis, (n=249) |
20.5 (51) |
14.3 (9) |
20.6 (13) |
19.4 (12) |
27.9 (17) |
0.311 2 |
20.6 (13) |
12.7 (8) |
26.7 (16) |
22.2 (14) |
0.2762 |
Diabetic nephropathy, (n=249) |
14.1 (35) |
22.2 (14) |
6.3 (4) |
16.1 (10) |
11.5 (7) |
0.068 2 |
15.9 (10) |
14.3 (9) |
16.7 (10) |
9.5 (6) |
0.6632 |
Hypertensive kidney disease, (n=249) |
24.9 (62) |
25.4 (16) |
25.4 (16) |
27.4 (17) |
21.3 (13) |
0.886 2 |
25.4 (16) |
25.4 (16) |
23.3 (14) |
25.4 (16) |
0.9912 |
Other, (n=249) |
40.6 (101) |
38.1 (24) |
47.6 (30) |
37.1 (23) |
39.3 (24) |
0.613 2 |
38.1 (24) |
47.6 (30) |
33.3 (20) |
42.9 (27) |
0.4082 |
Clinical variables | |||||||||||
Dialysis vintage, mo, (n=251) |
9.0 (5.0, 23.0) |
18.0 (6.0, 34.0) |
9.0 (4.0, 20.0) |
9.0 (5.0, 20.0) |
7.0 (3.4, 16.8) |
0.004np |
10.0 (4.0, 23.0) |
11.0 (5.0, 32.0) |
10.0 (5.0, 17.3) |
7.0 (4.0, 24.0) |
0.352np |
Previous graft failure, (251) |
18.7 (47) |
24.2 (15) |
11.1 (7) |
19.0 (12) |
20.6 (13) |
0.287 2 |
22.2 (14) |
17.5 (11) |
21.0 (13) |
14.3 (9) |
0.6612 |
Accepted for renal transplantation, (n=252) |
38.1 (96) |
28.6 (18) |
27.0 (17) |
49.2 (31) |
47.6 (30) |
0.012 |
36.5 (23) |
33.3 (21) |
42.9 (27) |
39.7 (25) |
0.7182 |
Peritoneal dialysis, (n=252) |
20.2 (51) |
23.8 (15) |
14.3 (9) |
27.0 (17) |
15.9 (10) |
0.221 2 |
14.3 (9) |
19.0 (12) |
31.7 (20) |
15.9 (10) |
0.0622 |
Body mass index, kg/m2, (n=235) |
24.9±4.9 |
23.6±5.0 |
25.5±4.8 |
24.9±4.6 |
25.5±5.0 |
0.135p |
23.7±4.5 |
25.2±4.4 |
25.0±4.6 |
25.9±5.8 |
0.124p |
Serum albumin, g/l, (n=246) |
38.0±4.8 |
36.6±5.9 |
37.7±4.4 |
38.4±4.3 |
39.1±4.0 |
0.022p |
38.7±3.9 |
37.8±4.4 |
38.1±5.5 |
37.4±5.2 |
0.503p |
Hemoglobin, g/dl, (n=246) |
12.1±1.5 |
12.0±1.4 |
12.1±1.5 |
12.2±1.5 |
12.2±1.4 |
0.87p |
11.8±1.6 |
12.1±1.3 |
12.4±1.5 |
12.2±1.3 |
0.139p |
Total cholesterol, mmol/L, (n=230) |
4.2±1.1 |
4.0±1.2 |
4.1±1.1 |
4.5±1.1 |
4.2±1.1 |
0.103p |
4.3±1.2 |
4.0±1.0 |
4.2±1.2 |
4.3±1.1 |
0.279p |
Comorbidity | |||||||||||
Diabetes, %, (n=250) |
26.4 (66) |
31.7 (20) |
28.6 (18) |
24.2 (15) |
21.0 (13) |
0.537 2 |
30.2 (19) |
33.3 (21) |
27.9 (17) |
14.3 (9) |
0.0772 |
CCI without age, (n=248) | 4 (2, 5) | 5 (4, 6) | 4 (2, 4) | 3 (2, 5) | 3 (2, 4) | <0.001np | 4 (3, 5) | 4 (3, 5) | 4 (2, 5) | 3 (2, 5) | 0.436np |
CCI Charlson modified comorbidity index. Continuous variables are given as mean ± SD, when normally distributed, or as median (IQR), when skewed. P-values between the four groups are calculated based on parametric (ANOVA)p , nonparametric (Kruskall Wallis)np, or Chi-squared2 statistics. Note: Numbers of complete data are given in parentheses for each variable.